Alafair BioSceinces Received Confirmation for Versacoat™ Nerve Protector and Versacoat™ Tendon Protector Announcement Alafair Biosciences, a well-established medical device company reshaping soft-tissue protection in orthopedic surgery, received a 510 (k) clearance from the FDA for...
Moderna’s Updated COVID-19 Vaccine Received Approval from the European Commission Announcement Moderna Inc. received a commercial authorization from the European Commission on the updated formulation of the COVID-19 vaccine known as Spikevax, focusing on the SARS-CoV-2 variant Lp 8.1 for...
W Health Ventures Funded Millions to Develop Healthcare Innovation in India Announcement W Health Ventures has raised a $70 million fund for the second time to help healthcare startups build from scratch. This valuable initiative reflects the firm’s commitment to the next-generation of h...
Xenetic and Periness Signed a ‘Clinical Study Agreement’ Announcement Xenetic Biosciences Inc., a leading biopharmaceutical company focused on developing and advancing innovative immune-oncology technologies, identifying treatments for cancer patients, partnered with Periness Ltd. ...
Natera Introduces ABCSG 61’s TEODOR Trial Announcement Natera Inc., a well-known leader in cell-free DNA and precision medicine, has begun a new TEODOR trial, a neoadjuvant treatment optimization featured by ctDNA and endocrine responsiveness. The TEODOR is a phase 2 multicenter, randomi...
Four Biotech Companies Standing Strong Against Market Waves A Drug Struggles Through Clinical Trials A drug typically takes around 10 to 15 years to undergo clinical trials, and after completing them, it reaches the final step of approval. There are more big tests on the way in the market spec...
Benecard and DecisionRX Formed a Partnership to Enhance Pharmacy Benefits Announcement DecisionRX, Inc., a key player in medication therapy optimization (MTO), and Benecard PBF, the original pharmacy benefit facilitator (PBF), entered into a strategic partnership initiated to introduce persona...
Kedrion’s COAGADEX® Received Confirmation of ‘Orphan Drug Designation' Announcement Kedrion Biopharma’s COAGADEX is now declared an orphan drug designation from the US Food and Drug Administration (FDA). The coagulation factor X human (tradename COAGADEX) will be a treatm...
Genethon's New Trial in Europe for Duchenne Muscular Dystrophy Announcement Genethon, a global prominent leader in research and development in gene therapy for rare genetic diseases, received approval from regulatory authorities, EMA and MHRA, for crucial phase 3 clinical trials in the UK and ...
Bristol and Bain Capital’s New Company Announcement Bristol-Myers Squibb and Bain Capital together have built a new independent biopharmaceutical company. A company that will be aiming the develop new treatments for autoimmune diseases that address the prominent needs of patients. The ne...
